Publicaciones en colaboración con investigadores/as de Harvard University (2)

2016

  1. Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): The SOFT-EST substudy

    Journal of Clinical Oncology, Vol. 34, Núm. 14, pp. 1584-1593

2015

  1. Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis

    Journal of the National Cancer Institute, Vol. 107, Núm. 12